Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3025]

Biomarkers of systemic inflammation linked to reduced clinical activity of...

Luciana Molinero - Genentech, San Francisco, USA

Biomarkers of systemic inflammation linked to reduced clinical activity of atezolizumab monotherapy in metastatic TNBC ( Luciana Molinero - Genentech, San Francisco, USA )

ADMIRAL: Gilteritinib as treatment for patients with relapsed or refractory...

Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA

$ADMIRAL: Gilteritinib as treatment for patients with relapsed or refractory acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )$

Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative...

Dr Constantia Pantelidou - Dana Farber Cancer Institute, Boston, USA

Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer ( Dr Constantia Pantelidou - Dana Farber Cancer Institute, Boston, USA )

Talimogene laherparepvec combined with neoadjuvant chemotherapy for non...

Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA

Talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer ( Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA )

Lymphodepleting chemotherapy in order to safely improve the expansion of HER2...

Prof Shoba Navai - Baylor College of Medicine, Houston, USA

Lymphodepleting chemotherapy in order to safely improve the expansion of HER2-CAR T cells in patients with advanced sarcomas ( Prof Shoba Navai - Baylor College of Medicine, Houston, USA )

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET...

Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI ( Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA )

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1...

Dr James Gulley - National Cancer Institute, Bethesda, USA

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies ( Dr James Gulley - National Cancer Institute, Bethesda, USA )

Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV...

Prof Kees Melief - Leiden University Medical Center, Leiden, Netherlands

Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV-specific T-cell response in cervical cancer ( Prof Kees Melief - Leiden University Medical Center, Leiden, Netherlands )

African Access Initiative: Improving patient outcomes in Africa

Jennifer Dent - BIO Ventures for Global Health, Seattle, USA

African Access Initiative: Improving patient outcomes in Africa ( Jennifer Dent - BIO Ventures for Global Health, Seattle, USA )

Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone...

Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA

$Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )$

Using regionally delivered autologous mesothelin-targeted CAR T cells in the...

Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA

Using regionally delivered autologous mesothelin-targeted CAR T cells in the treatment of malignant pleural disease ( Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA )

Importance of capacity development for African researchers

Dr Soloman Rotimi - Covenant University, Ota, Nigeria

Importance of capacity development for African researchers ( Dr Soloman Rotimi - Covenant University, Ota, Nigeria )

More from ecancer